Intelligence · Clinical Development
Pipeline search results
Programs matching “capecitabine” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 38 pipeline programs matching "capecitabine" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Capecitabine+Cisplatin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Stomach Neoplasms
1 trial -
Capecitabine-Oxaliplatin-Irinotecan Combination
The First People's Hospital of Lianyungang
Unresectable Metastatic Colorectal Cancer
1 trial -
Cisplatin+Capecitabine+Sintilimab
The First People's Hospital of Lianyungang
Esophageal Squamous Cell Carcinoma
1 trial -
Mektovi film-coated tablets for metastatic colorectal cancer wi…
Disc Medicine
metastatic colorectal cancer with a proven RAS mutation after failure of standard systemic treatment regimens including at least 5- FU/capecitabine-oxaliplatin and irinotecan based standard treatment (unless contra-indications for either oxaliplatin or irinotecan)
1 trial -
PCS6422 and capecitabine
Processa Pharmaceuticals
Breast Cancer
1 trial -
TAR-0520 Gel
Lacuna Pharma Pty Ltd
Capecitabine-induced hand and foot syndrome
1 trial -
TAX625
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Advanced Breast Cancer
1 trial -
UC-GIG-2311
Ningbo Cancer Hospital
Fluoropyrimidine (FP)-naive patients with gastrointestinal (GI) cancer and available pre-treatment uracilemia ([U]) starting chemotherapy combining FP (5FU or capecitabine) and oxaliplatin for any indication
1 trial -
capecitabine
Cardiff Oncology
Pancreatic Cancer
1 trial -
combination with Disitamab Vedotin and with Tislelizumab and Capecitabine
Hospital Authority, Hong Kong
Gastric Cancer
1 trial -
PCS6422 and capecitabine
Processa Pharmaceuticals
Advanced Cancer
1 trial -
WX-UK1 in combination with Capecitabine
United Therapeutics Europe Ltd
Advanced Malignancies
1 trial -
standard dose capecitabine
Karyopharm Therapeutics Inc
Rectal Neoplasms
1 trial -
OXALIPLATIN, CAPECITABINE
Disc Medicine
Locally advanced or metastatic gastro-intestinal carcinoma
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.